Omalizumab Monoclonal Antibody from Japan
Omalizumab (Xolair) recombinant humanized monoclonal antibody binds IgE for severe asthma treatment. HTS 3002.13.0010 for unmixed monoclonal immunologicals from biotech processes. Bulk pharmaceutical grade.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Provide IgE binding specificity certificates
• Comply with PATENT Act for biologics exclusivity
• Avoid colloidal suspensions to stay 'unmixed'